コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 vity against an array of multidrug-resistant staphylococci.
2 aB inhibitors to combat biofilm formation by staphylococci.
3 Ps) are highly conserved in streptococci and staphylococci.
4 hibit the growth and virulence of pathogenic staphylococci.
5 erial adhesins conserved in streptococci and staphylococci.
6 card for Enterococcus and the API system for staphylococci.
7 esins that are conserved in streptococci and staphylococci.
8 Hla might prevent invasive skin infection by staphylococci.
9 ment of 25 cases of CIED endocarditis due to staphylococci.
10 Cmec) by horizontal gene transfer from other staphylococci.
11 Gap3 are conserved in many streptococci and staphylococci.
12 y of biofilm growth with special emphasis on staphylococci.
13 nd complements the tagO mutant phenotypes of staphylococci.
14 patients infected with methicillin-sensitive staphylococci.
15 without inappropriate amplification of other staphylococci.
16 C test could predict the presence of mecA in staphylococci.
17 tively distinguish S. lugdunensis from other staphylococci.
18 f S. aureus when one of two cultures yielded staphylococci.
19 wo cultures is positive by Gram staining for staphylococci.
20 and antimicrobial resistance determinants of staphylococci.
21 s that have not been previously described in staphylococci.
22 nterpretations of nonsusceptible results for staphylococci.
23 Linezolid coverage was >98% against staphylococci.
24 LTA synthesis and the growth of ltaS mutant staphylococci.
25 n and the risk of resistance to mupirocin in staphylococci.
26 ss bridges of peptidoglycan, thereby killing staphylococci.
27 ococci (all E. faecium) but none (0/22) with staphylococci.
28 mecA-mediated oxacillin resistance in canine staphylococci.
29 id (ypfP) bound GFP-CWT similar to wild-type staphylococci.
30 suggesting a common regulatory mechanism in staphylococci.
31 ts in a manner similar to that for wild-type staphylococci.
32 moglobin and transport of this compound into staphylococci.
33 es-specific association of the reporter with staphylococci.
34 ate resistance to beta-lactam antibiotics in staphylococci.
35 disease caused by S. epidermidis and related staphylococci.
36 itis, compared with other coagulase-negative staphylococci.
37 ating persisting intracellular reservoirs of staphylococci.
38 a-sheet peptide) against multidrug resistant staphylococci.
39 ing-protein 2a of methicillin resistant (MR) staphylococci.
40 e predominant isolate was coagulase negative Staphylococci.
41 terotoxins excreted into foods by strains of staphylococci.
42 cal bacteria in addition to streptococci and staphylococci.
43 identified and readily transferred to other staphylococci.
44 gowns was performed with coagulase-negative staphylococci.
45 lococci, 15 strains of methicillin-sensitive staphylococci, 10 strains of heterologous genera (all at
47 the sensor was tested with 36 strains of MR staphylococci, 15 strains of methicillin-sensitive staph
49 n oncology locations were coagulase-negative staphylococci (16.9%), Escherichia coli (11.8%), and Ent
50 ermidis (MSSE) (9), other coagulase-negative staphylococci (19), Streptococcus salivarius (5), Strept
51 Common pathogens were coagulase-negative staphylococci (21%, 10/48) and methicillin-sensitive Sta
52 ausal microorganisms were coagulase-negative staphylococci (24%), followed by Staphylococcus aureus (
55 nerated data showed that oxacillin-resistant staphylococci (57.0% overall) had slightly higher dalbav
57 terquartile range, 59.8-77.6]); causation by staphylococci (62 [35.0% {95% CI, 28.0%-42.5%}] Staphylo
58 ne were active against oxacillin-susceptible staphylococci (82 to 99% susceptible), with lower suscep
62 dards Institute were compared by testing 567 staphylococci against trimethoprim-sulfamethoxazole.
65 This resulted in 13.6% VM errors (3/22) with staphylococci and 14.3% VM errors (2/14) with enterococc
68 siella pneumoniae whereas Coagulase negative Staphylococci and Bacillus spp. are common causes of pos
69 This study generated susceptibility data for staphylococci and beta-hemolytic streptococci from 52 U.
70 t of wall teichoic acid (WTA) in bacilli and staphylococci and capsular polysaccharides (CPS) in stre
71 ctic acid bacteria were always present while staphylococci and coliform bacteria disappeared after 30
72 household transmission of S aureus and other staphylococci and describes contamination of household e
73 32-fold underestimation of activity against staphylococci and enterococci because of oritavancin's s
75 lightly declined, whereas coagulase-negative staphylococci and enterococci consistently increased ove
76 pparent increase in linezolid-nonsusceptible staphylococci and enterococci following a laboratory cha
77 recent emergence of linezolid-nonsusceptible staphylococci and enterococci is providing a challenge f
78 lity testing (AST) of challenge and clinical staphylococci and enterococci recovered from patients in
81 m-positive pathogens: vancomycin-susceptible staphylococci and enterococci, glycopeptide-intermediate
82 ethod for detecting linezolid-nonsusceptible staphylococci and enterococci, MicroScan results showed
87 ymes to their close relatives throughout the staphylococci and explore the substrate specificities of
88 teins are conserved in many streptococci and staphylococci and have been implicated in bacterial viru
90 m was an early event in the evolution of the staphylococci and long preceded the development of the n
95 also studied; fsrB is a homologue of agrB of staphylococci and participates in regulation of gelE-spr
96 ibodies, which trigger phagocytic killing of staphylococci and protect mice against lethal bloodstrea
98 icting mecA-mediated oxacillin resistance in staphylococci and revised Table 2C in CLSI document M100
99 ibacterial compound active against resistant staphylococci and some clinically relevant Gram negative
102 cies; this may have clinical relevance since staphylococci and streptococci are the most common cause
103 ads among bacteria, with multidrug-resistant staphylococci and streptococci infections posing major t
106 comparative population genetics results for staphylococci and the first statistical evidence for a c
108 lieve the environmental hit in AD relates to staphylococci and their biofilms, which occlude sweat du
109 bility testing of other beta-lactams against staphylococci and to indicate that susceptibility to the
110 of TarM revealed an ancient origin in other staphylococci and vertical inheritance during S. aureus
111 s cultured were typically coagulase-negative staphylococci and were associated with increased levels
113 6% {95% CI, 24.9%-39.0%}] coagulase-negative staphylococci); and a high prevalence of health care-ass
114 ia, including enterococci, streptococci, and staphylococci, and antibodies against LTA have been show
115 ropionibacterium species, coagulase-negative staphylococci, and Corynebacterium species were the micr
117 om three gram-positive species (pneumococci, staphylococci, and group B streptococci) during the expo
119 glycoproteins are conserved in streptococci, staphylococci, and lactobacilli, and are required for ba
120 porting recommendations for beta-lactams and staphylococci, and microbiologic data and clinical data
121 ded gram-positive cocci (45%), predominantly staphylococci, and nosocomial gram-negative bacilli (27%
122 cally relevant pathogens (e.g., enterococci, staphylococci, and streptococci) are Gram-positive (G+),
123 micin, possess activity against Enterococci, Staphylococci, and Streptococci, and other Gram-positive
124 rynebacterium, Acinetobacter, Brevundimonas, Staphylococci, Aquabacterium, Sphingomonas, Streptococcu
128 sions requires that these coagulase-positive staphylococci are accurately identified and specifically
130 y Sec (SecA2/Y2) systems of streptococci and staphylococci are dedicated to the transport of large se
131 Further, EsaC production is repressed when staphylococci are grown in broth and increased when stap
132 ycoproteins identified from streptococci and staphylococci are important for bacterial adhesion and b
133 oteins (SRRPs) conserved in streptococci and staphylococci are important for bacterial colonization a
135 medical devices by common pathogens such as staphylococci are not only associated with increased mor
139 gram-positive (G(+)) bacteria, most commonly staphylococci, are thought to be the main pathogens.
140 contributes to the extraordinary success of staphylococci as colonizers and infective agents on huma
141 cultural findings showing coagulase-negative staphylococci as the most common isolates (68%) in prost
142 p with cellular GTPases is not unique to the staphylococci, as homologs from Bacillus subtilis and En
144 ploits the specificity and physiology of the Staphylococci bacteriophage K to identify Staphylococcus
145 In post-meconium samples, the abundance of staphylococci became negatively associated with NEC deve
148 ction of inducible clindamycin resistance in staphylococci, but only a disk approximation test for th
149 e not yet known, opsonophagocytic killing of staphylococci by phagocytic cells offers opportunities t
150 Taken together, MyD88-dependent sensing of staphylococci by resident dermal Mvarphis is key for a r
151 t, we characterize a genetic locus unique to staphylococci called rsr that has a role in repressing t
154 ve poor final acuity than coagulase-negative staphylococci cases (adjusted OR, 11.28; 95% CI, 3.63-35
156 Staphylococcus aureus and coagulase-negative staphylococci clinical isolates cultured at our institut
157 sistance of S. aureus and coagulase negative staphylococci clinical isolates to tetracycline or rifam
159 he dominant isolates were Coagulase negative Staphylococci (CNS) 9(29.0%), Staphylococcus aureus (S.
162 s, Staphylococcus aureus, coagulase-negative staphylococci (CNS), Peptostreptococcus spp., Bacteroide
164 ted pathogen, followed by Coagulase negative staphylococci (CoNS) (33.5%) and Klebsiella species (4.7
165 organisms identified were Coagulase-negative Staphylococci (CoNS) [65.9% (91/138)] and Staphylococcus
166 ferentiate S. aureus from coagulase-negative staphylococci (CoNS) and other Gram-positive cocci (GPC)
168 transfer originating from coagulase-negative staphylococci (CoNS) and through clonal transmission.
172 e, virulent member of the coagulase-negative staphylococci (CoNS) that is responsible for severe, rap
173 s-level identification of coagulase-negative staphylococci (CoNS) using matrix-assisted laser desorpt
174 Staphylococcus aureus and coagulase-negative staphylococci (CoNS) were 99.5% (217/218) and 98.8% (487
176 s, a 1.4-fold increase in coagulase-negative staphylococci (CoNS), and a 3.9-fold increase in other b
177 ant S. aureus (MRSA), and coagulase-negative staphylococci (CoNS), including methicillin-resistant Co
178 of Staphylococcus aureus, coagulase-negative staphylococci (CoNS), Streptococcus pneumoniae, Haemophi
180 caused by enterococci and coagulase-negative staphylococci (CoNS; adjusted SHR, 0.91; 95% CI, .50-1.6
181 reviews beta-lactam resistance mechanisms in staphylococci, current antimicrobial susceptibility test
182 ed tissues using a specific antibody against staphylococci demonstrated the presence of thick clumps
183 reaction for species-level identification of staphylococci, detection of genes encoding Panton-Valent
186 ss lesions into purulent exudate, with which staphylococci disseminate to produce new infectious lesi
190 ng Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, E. faecium, E. avi
194 portions were highest for coagulase-negative staphylococci followed by gram-negative rods and Staphyl
195 cycle activity can be induced by preventing staphylococci from exogenously acquiring a TCA cycle-der
199 such as vancomycin-resistant Enterococci and Staphylococci has become a major global health hazard.
200 y indicate that quorum-sensing regulation in staphylococci has important, previously unknown function
201 CR), which confers methicillin resistance in staphylococci, has the added potential to reduce antibio
202 s in 5.8% (26/443), other coagulase-negative staphylococci in 6.0% (27/448), Propionibacterium acnes
203 le modulins, surfactant peptides secreted by staphylococci in a quorum-sensing controlled fashion, st
205 e associated with reduced survival of mutant staphylococci in blood and diminished virulence in mice.
208 sor described has the potential to detect MR staphylococci in clinical samples with a high degree of
211 rated activity against methicillin-resistant staphylococci including investigational cephalosporins,
212 ctive in vitro bactericidal activity against staphylococci, including methicillin- and multi-drug-res
213 showed strong antibacterial activity against staphylococci, including MRSA strain, but did not affect
217 ne responsible for methicillin resistance in staphylococci, inserts into the chromosome at a specific
218 y to recruit PML within hours in response to staphylococci, irrespective of bacterial viability.
220 though the agr system is conserved among the staphylococci, it has undergone significant evolutionary
221 occi were less bactericidal and cocolonizing staphylococci less susceptible to this effect; however,
222 icillin and other beta-lactam antibiotics in staphylococci, mecA, is carried on a genomic island, SCC
223 he accessory Sec systems of streptococci and staphylococci mediate the transport of a family of large
224 rug has demonstrated potent activity against staphylococci (minimum inhibitory concentration [MIC] fo
225 confirm whether colonization with commensal staphylococci modulates skin immunity and attenuates dev
226 on, which in turn renders the lukAB-negative staphylococci more susceptible to killing by neutrophils
227 biology of the disease has also changed, and staphylococci, most often associated with health-care co
229 challenge panel of enterococci (n = 50) and staphylococci (n = 50), including 17 and 15 isolates tha
232 nd other superantigens by coagulase-negative staphylococci, no associated pathogenicity islands have
235 ne sensitivity testing in coagulase-negative staphylococci often lead to the use of potentially less-
236 Agr is a global regulatory system in the staphylococci, operating by a classical two-component si
237 e samples (730) contained coagulase-negative staphylococci or nonstaphylococci as assessed by the Qui
238 to cause serious diseases from the vaginal (staphylococci) or oral mucosa (streptococci) of the body
239 cin-intermediate S. aureus isolates; and 102 staphylococci other than S. aureus (non-S. aureus).
241 niae and Escherichia coli in Conjunctivitis; Staphylococci, P. aeruginosa and E. coli in dacryocystit
244 . coli in dacryocystitis; Coagulase negative Staphylococci, Pseudomonas aeruginosa and Staphylococcus
245 bacter, Enterobacter, and coagulase-negative staphylococci recovered from the hands and immediate env
246 ococci are grown in broth and increased when staphylococci replicate in serum or infected hosts.
247 l as collagen deposits and immune cells with staphylococci replicating at the center of these lesions
252 er dividing the isolates into two subgroups, staphylococci, streptococci, and enterococci (n = 217) a
253 tection of 12 different organisms, including staphylococci, streptococci, and enterococci, as well as
255 e identification of 305 clinical isolates of staphylococci, streptococci, and related genera by compa
256 eral, regional differences in activity among staphylococci, streptococci, Haemophilus spp., and Morax
257 S rRNA gene PCR/pyrosequencing as containing staphylococci, streptococci, or enteric Gram-negative ro
258 w, Staphylococcus aureus, Coagulase negative Staphylococci, Streptococcus pneumoniae and Pseudomonas
259 of the respective clinical diagnose include Staphylococci, Streptococcus pyogenes and Pseudomonas ae
260 s and Pseudomonas aeruginosa in blepharitis; Staphylococci, Streptococus pneumoniae, Pseudomonas aeru
261 in 2009, the CLSI altered the guidelines for staphylococci such that disk diffusion was no longer an
262 soluble hTSP-1 to proteolytically pretreated staphylococci suggested a proteinaceous nature of potent
264 14- to 17-kb mobile pathogenicity islands in staphylococci that carry genes for superantigen toxins a
265 esins found in a variety of streptococci and staphylococci that have been implicated in bacterial pat
270 ic gram-positive cocci (GPC), and especially staphylococci, the most common causative organisms.
272 Although early colonization is dominated by Staphylococci, their significant decline contributes to
275 dispensable for the early immune response to staphylococci, they contributed to Mvarphi renewal after
276 rial adhesins found in many streptococci and staphylococci; they play important roles in bacterial bi
279 , leading to increased binding of CS-treated staphylococci to immobilized fibronectin and increased a
280 ted binding efficiency for late growth phase staphylococci to immobilized platelets, compared with th
281 lammatory cell death, which was required for staphylococci to penetrate across a keratinocyte barrier
282 tic resistance genes and immunizes avirulent staphylococci to prevent the spread of plasmid-borne res
283 vidual transcript responses to Hla-secreting staphylococci was notable for upregulation of host cytok
287 of 73% contamination when coagulase-negative staphylococci were identified, 67.6% prevalence of risk
297 Phi function is supported by the response to staphylococci, where TLR13 and UNC-93B limit the cytokin
298 ed wall peptides, blocked GFP-CWT binding to staphylococci, whereas murein monomers or lysostaphin-so
299 cross-walls and in the relative abundance of staphylococci with cross-walls, suggesting that spd muta
300 fected samples contained multidrug-resistant staphylococci, with S aureus (42.0%) and Staphylococcus
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。